Catheter ablation, commonly referred to as endocardial ablation, is a procedural technique designed to address heart rhythm irregularities stemming from abnormal electrical pathways within the heart. In this minimally invasive approach, a catheter—a slender, flexible tube—is navigated through blood vessels to access the heart. Precision is key as the catheter delivers controlled bursts of energy, typically utilizing radiofrequency or cryotherapy, to selectively modify or eliminate tissue responsible for the generation of irregular electrical signals. Primarily employed for conditions such as atrial fibrillation, atrial flutter, and supraventricular tachycardia, endocardial ablation aims to disrupt aberrant pathways and restore a regular heart rhythm. The overarching goal is to alleviate symptoms including palpitations, fatigue, and shortness of breath. Endocardial ablation stands as an increasingly utilized and effective intervention, offering patients a potential avenue for managing and enhancing their cardiac health. As with any medical procedure, it's important to note that individual cases may exhibit variations, and healthcare professionals will thoroughly assess each patient's unique condition to determine the most suitable and personalized course of treatment.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt